{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:27:37Z","timestamp":1742801257923},"reference-count":34,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej13-0359","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T23:04:20Z","timestamp":1382396660000},"page":"91-99","source":"Crossref","is-referenced-by-count":7,"title":["The evolution of non-diabetic hyperglycemia: a longitudinal study"],"prefix":"10.1507","volume":"61","author":[{"given":"Rie","family":"Oka","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hokuriku Central Hospital, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunimasa","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yamada","sequence":"additional","affiliation":[{"name":"Data Science, Clinical Research Department, Kissei Pharmaceutical, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Fumisawa","sequence":"additional","affiliation":[{"name":"Rehabilitation Center, Aizawa Hospital, Matsumoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Diabetes Center, Aizawa Hospital, Matsumoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Diabetes Center, Aizawa Hospital, Matsumoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Tataranni PA, Bogardus C (2004) Metabolic abnormalities in the development of type 2 diabetes mellitus. In: LeRoith D, Olefsky JM, Taylor SI (eds) Diabetes Mellitus: A Fundamental and Clinical Text (3<sup>rd<\/sup> ed). Lippincott Williams & Wilkins, Philadelphia: 797-807."},{"key":"2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-J&auml;rvinen H, et al. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. <i>N Engl J Med<\/i> 318: 1217-1225.","DOI":"10.1056\/NEJM198805123181901"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Warram JH, Sigal RJ, Martin BC, Krolewski AS, Soeldner JS (1996) Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. <i>Diabet Med<\/i> 13(9 Suppl 6): S40-45.","DOI":"10.1002\/dme.1996.13.s6.40"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. <i>Diabetes Care<\/i> 24: 89-94.","DOI":"10.2337\/diacare.24.1.89"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Goldfine AB, Bouche C, Parker RA, Kim C, Kerivan A, et al. (2003) Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. <i>Proc Natl Acad Sci U S A<\/i> 100: 2724-2729.","DOI":"10.1073\/pnas.0438009100"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tab&aacute;k AG, Jokela M, Akbaraly TN, Brunner EJ, Kivim&auml;ki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. <i>Lancet<\/i> 373: 2215-2221.","DOI":"10.1016\/S0140-6736(09)60619-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Faerch K, Vaag A, Holst JJ, Hansen T, J&oslash;rgensen T, et al. (2009) Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. <i>Diabetes Care<\/i> 32: 439-444.","DOI":"10.2337\/dc08-1195"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, et al.; RISC Investigators (2011) Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. <i>Diabetologia<\/i> 54: 1507-1516.","DOI":"10.1007\/s00125-011-2112-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. <i>Diabetes Care<\/i> 20: 537-544.","DOI":"10.2337\/diacare.20.4.537"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tuomilehto J, Lindstr&ouml;m J, Eriksson JG, Valle TT, H&auml;m&auml;l&auml;inen H, et al.; Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. <i>N Engl J Med<\/i> 344: 1343-1350.","DOI":"10.1056\/NEJM200105033441801"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al.; Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. <i>N Engl J Med<\/i> 346: 393-403.","DOI":"10.1056\/NEJMoa012512"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. No authors listed (2011) The diabetes pandemic.<i> Lancet<\/i> 378: 99.","DOI":"10.1016\/S0140-6736(11)61068-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, et al. (1995) Proinsulin as a marker for the development of NIDDM in Japanese-American men. <i>Diabetes <\/i>44: 173-179.","DOI":"10.2337\/diab.44.2.173"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nagi DK, Knowler WC, Mohamed-Ali V, Bennett PH, Yudkin JS (1998) Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes. <i>Diabetes Care<\/i> 21: 127-133.","DOI":"10.2337\/diacare.21.1.127"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Larsson H, Ahr&eacute;n B (1999) Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. <i>J Clin Endocrinol Metab <\/i>84: 2068-2074.","DOI":"10.1210\/jc.84.6.2068"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Grill V, Dinesen B, Carlsson S, Efendic S, Pedersen O, et al. (2002) Ostenson CG. Hyperproinsulinemia and proinsulin-to-insulin ratios in Swedish middle-aged men: association with glycemia and insulin resistance but not with family history of diabetes. <i>Am J Epidemiol<\/i> 155: 834-841.","DOI":"10.1093\/aje\/155.9.834"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oka R, Yagi K, Sakurai M, Nakamura K, Moriuchi T, et al. (2012) Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. <i>Endocr J<\/i> 59: 55-64.","DOI":"10.1507\/endocrj.EJ11-0157"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al., The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus (2003) <i>Diabetes Care <\/i>26: 3160-3167.","DOI":"10.2337\/diacare.26.11.3160"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Marcovina S, Bowsher RR, Miller WG, Staten M, Myers G, et al.; Insulin Standardization Workgroup (2007) Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. <i>Clin Chem<\/i> 53: 711-716.","DOI":"10.1373\/clinchem.2006.082214"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. <i>Diabetes Care<\/i> 22: 1462-1470.","DOI":"10.2337\/diacare.22.9.1462"},{"key":"22","unstructured":"22. DeFronzo RA, Matsuda M (2010) Reduced time points to calculate the composite index. <i>Diabetes Care<\/i> 33: e93."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. <i>J Clin Endocrinol Metab<\/i> 85: 2402-2410.","DOI":"10.1210\/jcem.85.7.6661"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, et al. (2003) Novel insulin sensitivity index derived from oral glucose tolerance test. <i>J Clin Endocrinol Metab<\/i> 88: 1019-1023.","DOI":"10.1210\/jc.2002-021127"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-J&auml;rvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. <i>Diabetes Care <\/i>23: 295-301.","DOI":"10.2337\/diacare.23.3.295"},{"key":"26","unstructured":"26. https:\/\/www.dtu.ox.ac.uk\/homacalculator\/index.php"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. <i>Diabetologia<\/i> 28: 412-419.","DOI":"10.1007\/BF00280883"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. <i>J Clin Epidemiol<\/i> 49: 1373-1379.","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"29","unstructured":"29. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, et al.; American Diabetes Association (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. <i>Diabetes Care<\/i> 30: 753-759.","DOI":"10.2337\/dc07-9920"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Abdul-Ghani MA, Abdul-Ghani T, Stern MP, Karavic J, Tuomi T, et al. (2011) Two-step approach for the prediction of future type 2 diabetes risk. <i>Diabetes Care<\/i> 34: 2108-2112.","DOI":"10.2337\/dc10-2201"},{"key":"32","unstructured":"32. Falster DS, Warton DI, Wright IJ. SMATR: standardized major axis tests and routines, ver 2.0. Available from, http:\/\/www.bio.mq.edu.au\/ecology\/SMATR\/"},{"key":"33","unstructured":"33. Sokal RR, Rohlf FJ (2011) Biometry (4<sup>th<\/sup> ed). WH Freeman and Company, New York."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Warton DI, Wright IJ, Falster DS, Westoby M (2006) Bivariate line-fitting methods for allometry. <i>Biol Rev Camb Philos Soc<\/i> 81: 259-291.","DOI":"10.1017\/S1464793106007007"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/1\/61_EJ13-0359\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:39:58Z","timestamp":1618295998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/1\/61_EJ13-0359\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej13-0359","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}